Whats new
Whats new.
Maxim Group - Reports Half-Year Results; Eyeing the First External LAG-3 Approval from Bristol (Analyst: Dr Naureen Quibria)
February 23rd 2022
For a copy of this Analyst report please contact your Maxim advisor John Law - jlaw@maximgrp.com or biotech analyst Naureen Quibria - nquibria@maximgrp.com